{"denoms":[{"counts":[{"groupId":"BG000","value":"70"},{"groupId":"BG001","value":"71"},{"groupId":"BG002","value":"69"},{"groupId":"BG003","value":"210"}],"units":"Participants"}],"groups":[{"description":"Patients receive tacrolimus IV or PO every 12 hours on days -3 to 180 with taper beginning on day 100 in the absence of GVHD. Patients also receive MMF PO every 8 hours on days 0-29 and then every 12 hours on days 30-96 with taper beginning on day 40 in the absence of GVHD.\n\nFludarabine Phosphate: Given IV\n\nTotal-Body Irradiation: Undergo total-body irradiation\n\nPeripheral Blood Stem Cell Transplantation: Undergo allogeneic peripheral blood stem cell transplantation\n\nAllogeneic Hematopoietic Stem Cell Transplantation: Undergo allogeneic peripheral blood stem cell transplantation\n\nTacrolimus: Given IV or PO\n\nMycophenolate Mofetil: Given PO","id":"BG000","title":"Arm I (MMF and Tacrolimus)"},{"description":"Patients receive tacrolimus IV or PO every 12 hours on days -3 to 150 with taper beginning on day 100 in the absence of GVHD. Patients also receive MMF PO every 8 hours on days 0-29 and then every 12 hours on days 30-180 with taper beginning on day 150 in the absence of GVHD.\n\nFludarabine Phosphate: Given IV\n\nTotal-Body Irradiation: Undergo total-body irradiation\n\nPeripheral Blood Stem Cell Transplantation: Undergo allogeneic peripheral blood stem cell transplantation\n\nAllogeneic Hematopoietic Stem Cell Transplantation: Undergo allogeneic peripheral blood stem cell transplantation\n\nTacrolimus: Given IV or PO\n\nMycophenolate Mofetil: Given PO","id":"BG001","title":"Arm II (MMF and Tacrolimus Alternate Schedule)"},{"description":"Patients receive tacrolimus and MMF as in arm II. Patients also receive sirolimus PO once daily on days -3 to 80.\n\nFludarabine Phosphate: Given IV\n\nTotal-Body Irradiation: Undergo total-body irradiation\n\nPeripheral Blood Stem Cell Transplantation: Undergo allogeneic peripheral blood stem cell transplantation\n\nAllogeneic Hematopoietic Stem Cell Transplantation: Undergo allogeneic peripheral blood stem cell transplantation\n\nTacrolimus: Given IV or PO\n\nMycophenolate Mofetil: Given PO\n\nSirolimus: Given PO","id":"BG002","title":"Arm III (MMF, Tacrolimus, and Sirolimus)"},{"description":"Total of all reporting groups","id":"BG003","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"1"},{"groupId":"BG003","value":"2"}],"title":"<=18 years"},{"measurements":[{"groupId":"BG000","value":"57"},{"groupId":"BG001","value":"50"},{"groupId":"BG002","value":"49"},{"groupId":"BG003","value":"156"}],"title":"Between 18 and 65 years"},{"measurements":[{"groupId":"BG000","value":"13"},{"groupId":"BG001","value":"20"},{"groupId":"BG002","value":"19"},{"groupId":"BG003","value":"52"}],"title":">=65 years"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Age, Categorical","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"26","upperLimit":"74","value":"60"},{"groupId":"BG001","lowerLimit":"13","upperLimit":"72","value":"60"},{"groupId":"BG002","lowerLimit":"15","upperLimit":"75","value":"60"},{"groupId":"BG003","lowerLimit":"13","upperLimit":"75","value":"60"}]}]}],"dispersionType":"FULL_RANGE","paramType":"MEDIAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"29"},{"groupId":"BG001","value":"30"},{"groupId":"BG002","value":"23"},{"groupId":"BG003","value":"82"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"41"},{"groupId":"BG001","value":"41"},{"groupId":"BG002","value":"46"},{"groupId":"BG003","value":"128"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"59"},{"groupId":"BG001","value":"59"},{"groupId":"BG002","value":"58"},{"groupId":"BG003","value":"176"}]}],"title":"United States"},{"categories":[{"measurements":[{"groupId":"BG000","value":"5"},{"groupId":"BG001","value":"5"},{"groupId":"BG002","value":"5"},{"groupId":"BG003","value":"15"}]}],"title":"Denmark"},{"categories":[{"measurements":[{"groupId":"BG000","value":"6"},{"groupId":"BG001","value":"7"},{"groupId":"BG002","value":"6"},{"groupId":"BG003","value":"19"}]}],"title":"Germany"}],"paramType":"NUMBER","title":"Region of Enrollment","unitOfMeasure":"participants"}]}